Marks Group Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-72,182
Closed -$2.39M 295
2023
Q3
$2.39M Buy
72,182
+28,989
+67% +$1.03M 0.3% 103
2023
Q2
$1.58M Buy
43,193
+4,312
+11% +$168K 0.19% 137
2023
Q1
$1.59M Buy
38,881
+5,773
+17% +$249K 0.2% 131
2022
Q4
$1.7M Buy
33,108
+2,805
+9% +$134K 0.23% 123
2022
Q3
$1.33M Buy
30,303
+3,798
+14% +$185K 0.2% 130
2022
Q2
$1.39M Buy
26,505
+4,561
+21% +$232K 0.2% 136
2022
Q1
$1.14M Sell
21,944
-10,763
-33% -$558K 0.14% 155
2021
Q4
$1.93M Buy
32,707
+5,599
+21% +$277K 0.24% 120
2021
Q3
$1.17M Buy
27,108
+2,564
+10% +$114K 0.16% 142
2021
Q2
$960K Buy
24,544
+1,678
+7% +$65.3K 0.13% 143
2021
Q1
$830K Buy
22,866
+1,629
+8% +$57.8K 0.12% 145
2020
Q4
$782K Sell
21,237
-1,706
-7% -$62.6K 0.12% 151
2020
Q3
$799K Buy
22,943
+207
+0.9% +$7.26K 0.14% 143
2020
Q2
$703K Buy
22,736
+664
+3% +$22.6K 0.14% 139
2020
Q1
$682K Buy
22,072
+1,877
+9% +$64K 0.18% 134
2019
Q4
$751K Buy
+20,195
New +$719K 0.15% 149

Other funds holding PFE

Marks Group Wealth Management's PFE Position: Q4 2023 in Review

Marks Group Wealth Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 72,182 shares — an estimated $2.39M sold.

Marks Group Wealth Management first reported a position in PFE in Q4 2019 and held it in 16 quarters. The position peaked at $2.39M in Q3 2023. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Marks Group Wealth Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Marks Group Wealth Management sold 72,182 Pfizer shares in Q4 2023, an estimated $2.39M.
  • Marks Group Wealth Management first reported a position in Pfizer in Q4 2019 and held it in 16 quarters.
  • Marks Group Wealth Management's Pfizer position peaked at $2.39M in Q3 2023.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Marks Group Wealth Management's 13F filing for Q4 2023, filed 1 Feb 2024.